HCP2102

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCP2102, covering 2024-03-05 to 2024-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients [Phase 3]